Kemin’s patent declared valid and enforceable.

Kemin Foods, L.C., OmniActive Health Technologies, Inc. and OmniActive Health Technologies, Ltd. have reached a settlement on a patent dispute. The parties agree that Kemin's U.S. Patent No. 5,382,714 titled "Process for Isolation, Purification and Recrystallization of Lutein from Saponified Marigold Oleoresin and Uses Thereof" and the reissues of that patent are valid and enforceable.

In conjunction with the settlement, OmniActive will promote and sell its newly launched Lutemax 2020 products. The lawsuit, which was pending in federal court in Florida between the parties, has been dismissed.

The remaining terms of the settlement are confidential, according to Kemin, based in Des Moines, Iowa. OmniActive Health Technology’s U.S. offices are located in Short Hills, N.J.